Inhibikase Therapeutics, Inc. vs 4D Molecular Therapeutics, Inc., risk disclosures compared

2topics both disclose

4only Inhibikase Therapeutics, Inc.

2only 4D Molecular Therapeutics, Inc.

What both disclose

Topics appearing in filings from both companies, and how many filings each.

Topic	Inhibikase Therapeutics, Inc.	4D Molecular Therapeutics, Inc.
Internal Control	17	6
Restatement	2	5

Only Inhibikase Therapeutics, Inc.

Topic	Filings
AI Governance	1
Enforcement Action	1
Material Weakness	1
Records Retention	1

Only 4D Molecular Therapeutics, Inc.

Topic	Filings
Ransomware	3
Third Party Risk Management	3

What this compares

Which of the topics we track appear in each company's SEC filings, and how often. A topic appearing for one company and not the other means one wrote the phrase down and the other did not, in the filings we hold. It does not mean one faces a risk the other does not, and it is not a comparison of how well either manages anything.

Counts reflect the filings we have collected, which is a growing subset rather than a company's complete history.

Inhibikase Therapeutics, Inc. · 4D Molecular Therapeutics, Inc. · All companies